Patients with asthma who do not fill their inhaled corticosteroids: A study of primary nonadherence

被引:128
作者
Williams, L. Keoki
Joseph, Christine L.
Peterson, Edward L.
Wells, Karen
Wang, Mingqun
Chowdhry, Vimal K.
Walsh, Matthew
Campbell, Janis
Rand, Cynthia S.
Apter, Andrea J.
Lanfear, David E.
Tunceli, Kaan
Pladevall, Manel
机构
[1] Henry Ford Hosp, Dept Internal Med, Detroit, MI 48202 USA
[2] Henry Ford Hosp, Ctr Hlth Serv Res, Detroit, MI 48202 USA
[3] Henry Ford Hosp, Dept Biostat & Res Epidemiol, Detroit, MI 48202 USA
[4] Hlth Alliance Plan, Detroit, MI USA
[5] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
[6] Univ Penn, Med Ctr, Dept Med, Philadelphia, PA 19104 USA
关键词
primary nonadherence; inhaled corticosteroids; asthma race-ethnicity; controller medication;
D O I
10.1016/j.jaci.2007.08.020
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: Adherence to inhaled corticosteroids (ICSs) is known to be poor among patients with asthma; however, little is known about patients who do not fill their ICS prescriptions (ie, primary nonadherence). Objective: To estimate rates of primary nonadherence and to explore associated factors. Methods: The study population was members of a large health maintenance organization in southeast Michigan who met the following criteria: age 5 to 56 years; previous diagnosis of asthma; at least I electronic prescription for an ICS between February 17, 2005, and June 1, 2006; and at least 3 months follow-tip after the ICS prescription. Adherence was estimated by using electronic prescription information and pharmacy claims data. Multivariable stepwise analysis was used to identify factors associated with primary nonadherence compared with adherent patients. Results: One thousand sixty-four patients met the study criteria and bad calculable adherence. Of these patients, 82 (8%) never filled their ICS prescription. Stepwise regression identified the following factors to be associated with an increased likelihood of primary nonadherence: younger age, female sex, African American race-ethnicity, and lower rescue medication use. Factors associated with primary nonadherence differed between race-ethnic groups. Conclusion: Primary nonadherence was associated with lower baseline rescue medication use, which may reflect lower perceived need for ICS therapy in patients with milder asthma. Rates of primary nonadherence and the factors which influenced this outcome differed by race-ethnicity. Clinical implications: Understanding patient characteristics associated with primary nonadherence may be important for disease management, because many patients with asthma do not fill their ICS prescriptions.
引用
收藏
页码:1153 / 1159
页数:7
相关论文
共 50 条
  • [41] Risk of herpes zoster in patients prescribed inhaled corticosteroids: a cohort study
    Ernst, Pierre
    Dell'Aniello, Sophie
    Mikaeloff, Yann
    Suissa, Samy
    BMC PULMONARY MEDICINE, 2011, 11
  • [42] Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients?
    De Boeck, Kris
    De Baets, Frans
    Malfroot, Anne
    Desager, Kristine
    Mouchet, Francoise
    Proesmans, Marijke
    EUROPEAN JOURNAL OF PEDIATRICS, 2007, 166 (01) : 23 - 28
  • [43] Do inhaled corticosteroids impair long-term growth in prepubertal cystic fibrosis patients?
    Kris De Boeck
    Frans De Baets
    Anne Malfroot
    Kristine Desager
    Françoise Mouchet
    Marijke Proesmans
    European Journal of Pediatrics, 2007, 166 : 23 - 28
  • [44] The Effect of Inhaled Corticosteroids on the Concentration of Soluble CD163 in Induced Sputum of Allergic Asthma Patients
    Kowal, K.
    Moniuszko, M.
    Bodzenta-Lukaszyk, A.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2014, 24 (01) : 49 - 55
  • [45] Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids
    vanderMolen, T
    Postma, DS
    Turner, MO
    MeyboomdeJong, B
    Malo, JL
    Chapman, K
    Grossman, R
    deGraaff, CS
    Riemersma, RA
    Sears, MR
    THORAX, 1997, 52 (06) : 535 - 539
  • [46] Effect of inhaled corticosteroids on bronchial responsiveness in patients with "corticosteroid naive" mild asthma: a meta-analysis
    van Grunsven, PM
    van Schayck, CP
    Molema, J
    Akkermans, RP
    van Weel, C
    THORAX, 1999, 54 (04) : 316 - 322
  • [47] The beneficial role of FeNO in association with GINA guidelines for titration of inhaled corticosteroids in adult asthma: A randomized study
    Tung Truong-Thanh
    Anh Vo-Thi-Kim
    Thuc Vu-Minh
    Dung Truong-Viet
    Huong Tran-Van
    Sy Duong-Quy
    ADVANCES IN MEDICAL SCIENCES, 2020, 65 (02): : 244 - 251
  • [48] Asthma control in adult patients treated with a combination of inhaled corticosteroids and long-acting β2-agonists: a prospective observational study
    Rogala, Barbara
    Majak, Pawel
    Gluck, Joanna
    Debowski, Tomasz
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (02): : 100 - 106
  • [49] Effectiveness and Safety of Inhaled Corticosteroids in Older Individuals with Chronic Obstructive Pulmonary Disease and/or Asthma A Population Study
    Kendzerska, Tetyana
    Aaron, Shawn D.
    To, Teresa
    Licskai, Chris
    Stanbrook, Matthew
    Vozoris, Nicholas T.
    Hogan, Mary-Ellen
    Tan, Wan C.
    Bourbeau, Jean
    Gershon, Andrea S.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2019, 16 (10) : 1252 - 1262
  • [50] Inhaled Corticosteroids Prescribed for COPD Patients with Mild or Moderate Airflow Limitation: Who Warrants a Trial of Withdrawal?
    Harries, Timothy H.
    Gilworth, Gill
    Corrigan, Christopher J.
    Murphy, Patrick B.
    Hart, Nicholas
    Thomas, Mike
    White, Patrick T.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2019, 14 : 3063 - 3066